Skip to main content
رجوع
Watch Compare

IO Biotech, Inc.

جودة البيانات: 83%
مُدرج أيضًا باسم IOBTQ NASDAQ
IOBT
NASDAQ Manufacturing Chemicals
KWD 0.01
▲ KWD 0.01 (—)
6 months return
—
Momentum
Neutral
ROE
-7059.45%

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-7059.45%
أقل من متوسط القطاع (-54.68%)
ROIC-330.00%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
18.29
أعلى من متوسط القطاع (0.30)
Current Ratio2.01
Interest CoverageN/A

التقييم

PE (TTM|NTM)
-0.04 | -0.13
أعلى من متوسط القطاع (-1.49)
P/B Ratio3.79
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Debt/Equity of 18.29 — high leverage
Negative free cash flow of -81.07 M

Price History

الاتجاهات المالية

السعر المستهدف للمحللين

2 محللين
Hold
+27150.0%
upside to target
الحالي
KWD 0.01
Consensus Target
KWD 2.18
KWD 0.36
أدنى
KWD 4.00
أعلى
التوقعات
مكرر الربحية المستقبلي
-0.13
ربحية السهم المستقبلية
-KWD 0.36
الإيرادات المقدّرة
0.0

مفاجآت الأرباح

EPS
Reported Estimate Forecast
Next: Q1 2026 · Rev Est: 0.0
Q42024 Q12025 Q22025 Q32025 Q1 '26
Reported -KWD 0.46 -KWD 0.32 -KWD 0.33 -KWD 0.25 —
Estimate -KWD 0.38 -KWD 0.23 -KWD 0.30 -KWD 0.12 —
المفاجأة -18.70% -37.61% -11.43% -108.17% —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -7059.45% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -88.35 M
ROE -7059.45% ROA -214.75%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -81.07 M
ROIC -330.00% FCF Growth (3Y) N/A

Safety

D/E: 18.29 · Current: 2.01
Debt / Equity 18.29 Current Ratio 2.01
Interest Coverage N/A Asset Turnover N/A
Working Capital 18.52 M Tangible Book Value 911,000

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0.04 · EV/EBITDA: N/A
P/E Ratio -0.04 Forward P/E -0.13
P/B Ratio 3.79 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -2347.30%
Market Cap 3.45 M Enterprise Value -10.55 M

Per Share

EPS: -1.34 · FCF/Share: -1.13
EPS (Diluted TTM) -1.34 Revenue / Share N/A
FCF / Share -1.13 OCF / Share -1.13
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 91.76% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 91.76%
SBC-Adj. FCF -87.40 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Revenue — — — —
Net Income -95.49 M -86.08 M -71.46 M -67.88 M
EPS (Diluted) -1.45 -1.98 -2.48 —
Gross Profit — — — —
Operating Income -95.18 M -91.44 M -71.42 M -41.23 M
EBITDA — — — —
R&D Expenses 71.48 M 67.83 M 46.99 M 30.15 M
SG&A Expenses — — — —
D&A 300,000.0 200,000.0 100,000.0 —
Interest Expense — 302,000.0 302,000.0 361,000.0
Income Tax 1.44 M 852,000.0 1.27 M 68,000.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Total Assets 67.70 M 150.72 M 151.81 M 222.29 M
Total Liabilities 20.68 M 17.56 M 12.95 M 10.36 M
Shareholders' Equity 47.02 M 133.16 M 138.85 M 211.92 M
Total Debt 0.0 — — —
Cash & Equivalents 60.03 M 143.19 M 142.59 M 211.53 M
Current Assets 64.95 M 147.26 M 148.22 M 221.74 M
Current Liabilities 19.49 M 15.72 M 10.68 M 10.31 M

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1605 نظير)
المقياس السهم وسيط القطاع
P/E 0.0 -1.5
P/B 3.8 1.6
ROE % -7059.5 -54.7
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E 18.3 0.3

ETFs Holding This Stock
BRSIX BRSIX
0.08% weight